Northrop Grumman Q3 EPS Surpasses Estimates, Harel Increases Stake by 4.1%

NOCNOC

Northrop Grumman reported Q3 EPS of $7.67, beating estimates by $1.24 on revenues of $10.42 B vs. $10.68 B forecast and set FY 2025 EPS guidance at 25.650–26.050. Institutional investor Harel Insurance increased its stake by 4.1% to 81,747 shares ($49.8 M) and analysts’ average price target stands at $656.82.

1. Institutional Investment Uptick

Harel Insurance Investments & Financial Services Ltd. increased its stake in Northrop Grumman Corporation by 4.1% during the third quarter, raising its holding to 81,747 shares valued at $49.81 million. This move underscores growing confidence among institutional investors, with Harel’s position representing approximately 0.06% of the company. Other institutions, including Coign Capital Advisors LLC and Howard Financial Services Ltd., also modestly boosted their holdings, contributing to an overall institutional ownership level exceeding 83%.

2. Q3 Earnings Beat and 2025 Guidance

In the third quarter, Northrop Grumman reported adjusted earnings of $7.67 per share, surpassing analyst estimates by $1.24, while revenues of $10.42 billion were slightly below consensus. Revenue climbed 4.3% year-over-year, driven by higher program deliveries across aerospace and defense segments. The company reaffirmed full-year 2025 guidance of 25.650–26.050 earnings per share, and analysts forecast approximately 28.05 per share for the current year, reflecting steady growth in advanced mission systems and space platforms.

3. Dividend Policy and Payout Metrics

Northrop Grumman declared its quarterly dividend in December, translating to an annualized distribution of $9.24 and a payout ratio of 33.24%. The consistent dividend reflects the company’s commitment to returning capital to shareholders, supported by cash flow generation from long-term defense contracts and growing backlog in missile defense and C4ISR solutions.

4. Insider Transactions and Analyst Ratings

Recent filings reveal that CEO Kathy J. Warden sold 7,000 shares while Director Mark A. Welsh III disposed of 97 shares, reducing their respective holdings by 3.47% and 2.22%. Over the past 90 days, insiders have sold a total of 10,097 shares. On the analyst front, two firms upgraded their outlooks, raising the rating from neutral to overweight or outperform, while the consensus among nineteen analysts remains a Moderate Buy, reflecting balanced optimism about the company’s technology pipeline and defense spending trends.

Sources

GD